STAT3 and cancer: Acting downstream of multiple kinases and growth factor receptors, including but not limited to PDGFR, EGFR and IL-6, STAT3 is an important mediator of gliomagenesis through its role in modulating cancer cell survival, invasiveness, and immune evasion (Fig. 1B).